Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury

Stem Cell Research and Therapy

Volumn 5, Issue 4, 2014, Pages

  Xing, Li ^a   Cui, Rui ^a   Peng, Lei ^a   Ma, Jing ^a   Chen, Xiao ^a   Xie, Ru Juan ^a   Li, Bing ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; SCATTER FACTOR; SOMATOMEDIN C; VASCULOTROPIN A; CONDITIONED MEDIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL INFILTRATION; CELL PROLIFERATION; CONDITIONED CULTURE MEDIUM; CONTROLLED STUDY; CULTURE MEDIUM; GLOMERULUS CAPILLARY; HISTOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; MACROPHAGE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MORTALITY; MOUSE; NONHUMAN; PARACRINE SIGNALING; REPERFUSION INJURY; TISSUE REPAIR; ACUTE KIDNEY INJURY; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL THERAPY; CELL CULTURE TECHNIQUE; CONDITIONED MEDIUM; CYTOLOGY; MESENCHYMAL STROMA CELL; PATHOLOGY; PHARMACOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; CULTURE MEDIA, CONDITIONED; HEPATOCYTE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR I; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED BALB C; REPERFUSION INJURY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84908049482     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt489     Document Type: Article

References (45)

1. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, Rottoli D, Benigni A, Perico N, Zoja C, Stem Cells 2008 26 2075 2082 10.1634/stemcells.2007-0795 18499895
2. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Tögel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C, Am J Physiol Renal Physiol 2007 292 1626 F1635 10.1152/ajprenal.00339.2006 17213465
3. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Prodromidi EI, Poulsom R, Jeffery R, Roufosse CA, Pollard PJ, Pusey CD, Cook HT, Stem Cells 2006 24 2448 2455 10.1634/stemcells.2006-0201 16873763
4. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C, Am J Physiol Renal Physiol 2005 289 31 F42 10.1152/ajprenal.00007.2005 15713913
5. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, Rottoli D, Angioletti S, Benigni A, Perico N, J Am Soc Nephrol 2004 15 1794 1804 10.1097/01.ASN.0000128974.07460.34 15213267
6. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. Lin F, Cordes K, Li L, Hood L, Couser WG, Shankland SJ, Igarashi P, J Am Soc Nephrol 2003 14 1188 1199 10.1097/01.ASN.0000061595.28546.A0 12707389
7. Erythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice. Eliopoulos N, Zhao J, Forner K, Birman E, Young YK, Bouchentouf M, Mol Ther 2011 19 2072 2083 10.1038/mt.2011.162 21847101
8. Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Li B, Cohen A, Hudson TE, Motlagh D, Amrani DL, Duffield JS, Circulation 2010 121 2211 2220 10.1161/CIRCULATIONAHA.109.928796 20458011
9. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. Kunter U, Rong S, Boor P, Eitner F, Müller-Newen G, Djuric Z, van Roeyen CR, Konieczny A, Ostendorf T, Villa L, J Am Soc Nephrol 2007 18 1754 1764 10.1681/ASN.2007010044 17460140
10. Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells. Du T, Zou X, Cheng J, Wu S, Zhong L, Ju G, Zhu J, Liu G, Zhu Y, Xia S, Stem Cell Res Ther 2013 4 59 10.1186/scrt215 23734757
11. Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. Reis LA, Borges FT, Simões MJ, Borges AA, Sinigaglia-Coimbra R, Schor N, PLoS One 2012 7 44092 10.1371/journal.pone.0044092 22970165
12. Stromal cells protect against acute tubular injury via an endocrine effect. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG, J Am Soc Nephrol 2007 18 2486 2496 10.1681/ASN.2007020140 17656474
13. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Falda M, Bussolati B, Tetta C, J Am Soc Nephrol 2009 20 1053 1067 10.1681/ASN.2008070798 19389847
14. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia. Liew A, O'Brien T, Stem Cell Res Ther 2012 3 28 10.1186/scrt119 22846185
15. Mesenchymal stem cells in acute kidney injury. Humphreys BD, Bonventre JV, Annu Rev Med 2008 59 311 325 10.1146/annurev.med.59.061506.154239 17914926
16. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L, Blood 2006 107 1484 1490 10.1182/blood-2005-07-2775 16239427
17. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. Duffield JS, Park KM, Hsiao L, Kelley VR, Scadden DT, Ichimura T, Bonventre JV, J Clin Invest 2005 115 1743 10.1172/JCI22593 16007251
18. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ, Blood 2004 103 1662 1668 10.1182/blood-2003-09-3070 14592819
19. Macrophage stimulating protein may promote tubular regeneration after acute injury. Cantaluppi V, Biancone L, Romanazzi GM, Figliolini F, Beltramo S, Galimi F, Camboni MG, Deriu E, Conaldi P, Bottelli A, J Am Soc Nephrol 2008 19 1904 1918 10.1681/ASN.2007111209 18614774
20. Hospital-acquired renal insufficiency. Nash K, Hafeez A, Hou S, Am J Kidney Dis 2002 39 930 936 10.1053/ajkd.2002.32766 11979336
21. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM, Kidney Int 2004 66 1613 1621 10.1111/j.1523-1755.2004.00927.x 15458458
22. Acute kidney injury increases risk of ESRD among elderly. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ, J Am Soc Nephrol 2009 20 223 228 10.1681/ASN.2007080837 19020007
23. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Bagshaw SM, George C, Bellomo R, Nephrol Dial Transplant 2008 23 1569 1574 10.1093/ndt/gfn009 18281319
24. Stem cells and renal regeneration. Roufosse C, Cook H, Nephron Exp Nephrol 2008 109 39 e45 10.1159/000139989 18560247
25. Kidney repair and stem cells: a complex and controversial process. Yeagy BA, Cherqui S, Pediatr Nephrol 2011 26 1427 1434 10.1007/s00467-011-1789-x 21336814
26. Proximal tubular epithelial cells are generated by division of differentiated cells in the healthy kidney. Vogetseder A, Palan T, Bacic D, Kaissling B, Le Hir M, Am J Physiol Cell Physiol 2007 292 807 C813 16987990
27. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Basile DP, Donohoe D, Roethe K, Osborn JL, Am J Physiol Renal Physiol 2001 281 887 F899 11592947
28. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Basile D, Kidney Int 2007 72 151 156 10.1038/sj.ki.5002312 17495858
29. Challenges of targeting vascular stability in acute kidney injury. Basile DP, Kidney Int 2008 74 257 258 10.1038/ki.2008.243 18626492
30. Angiogenesis and endothelial cell repair in renal disease and allograft rejection. Reinders MEJ, Rabelink TJ, Briscoe DM, J Am Soc Nephrol 2006 17 932 942 10.1681/ASN.2005121250 16481411
31. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ, J Am Soc Nephrol 2001 12 1448 1457 11423573
32. Toward the identification of a 'renopoietic system'? Romagnani P, Stem Cells 2009 27 2247 2253 10.1002/stem.140 19739254
33. The evolving concept review of a stem cell: entity or function? Blau H, Brazelton T, Weimann J, Cell 2001 105 829 841 10.1016/S0092-8674(01)00409-3 11439179
34. Hematopoietic origin of glomerular mesangial cells. Masuya M, Drake CJ, Fleming PA, Reilly CM, Zeng H, Hill WD, Martin-Studdard A, Hess DC, Ogawa M, Blood 2003 101 2215 2218 10.1182/blood-2002-04-1076 12433693
35. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. Ito T, Suzuki A, Imai E, Okabe M, Hori M, J Am Soc Nephrol 2001 12 2625 2635 11729231
36. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Rookmaaker MB, Smits AM, Tolboom H, van't Wout K, Martens AC, Goldschmeding R, Joles JA, Van Zonneveld AJ, Gröne HJ, Rabelink TJ, Am J Pathol 2003 163 553 562 10.1016/S0002-9440(10)63683-8 12875975
37. Terminal differentiation is not a major determinant for the success of stem cell therapy-cross-talk between muscle-derived stem cells and host cells. Gharaibeh B, Lavasani M, Cummins JH, Huard J, Stem Cell Res Ther 2011 2 31 10.1186/scrt72 21745421
38. Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. Zarjou A, Kim J, Traylor AM, Sanders PW, Balla J, Agarwal A, Curtis LM, Am J Physiol Renal Physiol 2011 300 254 F262 10.1152/ajprenal.00594.2010 21048024
39. Stem cell-conditioned medium does not protect against kidney failure. Gheisari Y, Ahmadbeigi N, Naderi M, Nassiri SM, Nadri S, Soleimani M, Cell Biol Int 2011 35 209 213 10.1042/CBI20100183 20950276
40. Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. Lennon DP, Edmison JM, Caplan AI, J Cell Physiol 2001 187 345 355 10.1002/jcp.1081 11319758
41. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. Hung SC, Pochampally RR, Hsu SC, Sanchez C, Chen SC, Spees J, Prockop DJ, PLoS One 2007 2 416 10.1371/journal.pone.0000416 17476338
42. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, Wei L, J Thorac Cardiovasc Surg 2008 135 799 808 10.1016/j.jtcvs.2007.07.071 18374759
43. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Rosova I, Dao M, Capoccia B, Link D, Nolta JA, Stem Cells 2008 26 2173 2182 10.1634/stemcells.2007-1104 18511601
44. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Nat Med 2005 11 367 368 10.1038/nm0405-367 15812508
45. Topical delivery of mesenchymal stem cells and their function in wounds. Sorrell JM, Caplan AI, Stem Cell Res Ther 2010 1 30 10.1186/scrt30 20863417